Xenetic Biosciences (XBIO) came out with a quarterly loss of $0.83 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.69 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.79 per share when it actually produced a loss of $0.78, delivering a surprise of 1.27%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Xenetic Biosciences, which belongs ...